Home > Archive>Volume 50, Issue 7, 2023 >2970-2982. DOI:10.13344/j.microbiol.china.230128
PDF HTML XML Export Cite reminder
Therapeutic effect of Bacillus sp. DU-106 lysate on 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [42]
    • | | | |
  • Comments
    Abstract:

    [Background] Our research team have discovered that Bacillus sp. DU-106 has good health benefits in previous studies. However, the conclusion is based on the studies of living bacteria and the studies of inactivated bacteria remain to be carried out. [Objective] To investigate the effect and mechanism of Bacillus sp. DU-106 lysate in the treatment of atopic dermatitis. [Methods] Pathological observation and immunohistochemistry were employed to study the therapeutic effect of Bacillus sp. DU-106 lysate on the mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis. The expression levels of the proteins involved in the nuclear factor kappa-B (NF-κB) signaling pathway were determined to reveal the mechanism. [Results] Bacillus sp. DU-106 lysate alleviated the pathological changes, reduced the infiltration of mast cells, and lowered the levels of immunoglobulin E, tumor necrosis factor-α (TNF-α), and interferon-γ (P<0.05) in the model mice. Furthermore, Bacillus sp. DU-106 lysate down-regulated the expression levels and inhibited the phosphorylation of TNF-α, inhibitory kappa B kinase α (IKKα), and NF-κB in the NF-κB signaling pathway in the model mice. [Conclusion] Bacillus sp. DU-106 lysate can be used as a probiotic with therapeutic effects on atopic dermatitis.

    Reference
    [1] WEIDINGER S, NOVAK N. Atopic dermatitis[J]. The Lancet, 2016, 387(10023):1109-1122.
    [2] STÄNDER S. Atopic dermatitis[J]. The New England Journal of Medicine, 2021, 384(12):1136-1143.
    [3] CHO K, KANG MC, PARVEEN A, YUMNAM S, KIM SY. Anti-inflammatory effect of chloroform fraction of Pyrus ussuriensis maxim. leaf extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis in nc/nga mice[J]. Nutrients, 2019, 11(2):276.
    [4] MANDLIK DS, MANDLIK SK. Atopic dermatitis:new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies[J]. Immunopharmacology and Immunotoxicology, 2021, 43(2):105-125.
    [5] OECKINGHAUS A, HAYDEN MS, GHOSH S. Crosstalk in NF-κB signaling pathways[J]. Nature Immunology, 2011, 12(8):695-708.
    [6] DATTOLA A, BENNARDO L, SILVESTRI M, NISTICÒ SP. What's new in the treatment of atopic dermatitis?[J]. Dermatologic Therapy, 2019, 32(2):e12787.
    [7] LAI YJ, CHEN SM, LUO PH, LI P, DU B. Dietary supplementation of Bacillus sp. DU106 activates innate immunity and regulates intestinal microbiota in mice[J]. Journal of Functional Foods, 2020, 75:104247.
    [8] SANDERS ME, MERENSTEIN D, MERRIFIELD CA, HUTKINS R. Probiotics for human use[J]. Nutrition Bulletin, 2018, 43(3):212-225.
    [9] MAEHATA H, ARAI S, IWABUCHI N, ABE F. Immuno-modulation by heat-killed Lacticaseibacillus paracasei MCC1849 and its application to food products[J]. International Journal of Immunopathology and Pharmacology, 2021, 35:20587384211008291.
    [10] TAVERNITI V, GUGLIELMETTI S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics:proposal of paraprobiotic concept)[J]. Genes & Nutrition, 2011, 6(3):261-274.
    [11] PIQUÉ N, BERLANGA M, MIÑANA-GALBIS D. Health benefits of heat-killed (tyndallized) probiotics:an overview[J]. International Journal of Molecular Sciences, 2019, 20(10):2534.
    [12] AKTER S, PARK JH, JUNG HK. Potential health-promoting benefits of paraprobiotics, inactivated probiotic cells[J]. Journal of Microbiology and Biotechnology, 2020, 30(4):477-481.
    [13] SANAEI M, MAHDAVI M, SETAYESH N, SHAHVERDI AR, SEPEHRIZADEH Z, YAZDI MH. Comparison of cytokine expression in human PBMCs stimulated with normal and heat-shocked Lactobacillus plantarum cell lysate[J]. Probiotics and Antimicrobial Proteins, 2021, 13(6):1539-1545.
    [14] XIONG X, HUANG CQ, WANG FQ, DONG JL, ZHANG D, JIANG J, FENG Y, WU B, XIE TT, CHENG L. Qingxue Jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways[J]. Journal of Ethnopharmacology, 2021, 270:113773.
    [15] KARUPPAGOUNDER V, ARUMUGAM S, THANDAVARAYAN RA, SREEDHAR R, GIRIDHARAN VV, WATANABE K. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis[J]. Drug Discovery Today, 2016, 21(4):632-639.
    [16] KIM G, CHOI KH, KIM H, CHUNG DK. Alleviation of LPS-induced inflammation and septic shock by Lactiplantibacillus plantarum K8 lysates[J]. International Journal of Molecular Sciences, 2021, 22(11):5921.
    [17] ENOKIDA M, MINATO K, YOSHINO S, OHTO N, KUWAHARA H, MIZUNO M. Oral administration of Lactiplantibacillus plantarum 22A-3 exerts anti-allergic activity against intestinal food allergy mouse models sensitized and challenged with ovalbumin[J]. Food Bioscience, 2022, 47:101785.
    [18] BRANDI J, CHERI S, MANFREDI M, DI CARLO C, VITA VANELLA V, FEDERICI F, BOMBIERO E, BAZAJ A, RIZZI E, MANNA L, CORNAGLIA G, MARINI U, TERESA VALENTI M, MARENGO E, CECCONI D. Exploring the wound healing, anti-inflammatory, anti-pathogenic and proteomic effects of lactic acid bacteria on keratinocytes[J]. Scientific Reports, 2020, 10:11572.
    [19] GUÉNICHE A, BASTIEN P, OVIGNE JM, KERMICI M, COURCHAY G, CHEVALIER V, BRETON L, CASTIEL-HIGOUNENC I. Bifidobacterium longum lysate, a new ingredient for reactive skin[J]. Experimental Dermatology, 2010, 19(8):e1-e8.
    [20] LAU S. Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy[J]. Beneficial Microbes, 2014, 5(2):147-149.
    [21] LI P, TIAN WN, JIANG Z, LIANG ZH, WU XY, DU B. Genomic characterization and probiotic potency of Bacillus sp. DU-106, a highly effective producer of l-lactic acid isolated from fermented yogurt[J]. Frontiers in Microbiology, 2018, 9:2216.
    [22] HUANG DR, CHEN YL, CHEN HZ, DENG XY, HUANG JZ, LU SM, LI P, DU B. Supplementation of Bacillus sp. DU-106 alleviates antibiotic-associated diarrhea in association with the regulation of intestinal microbiota in mice[J]. Probiotics and Antimicrobial Proteins, 2022, 14(2):372-383.
    [23] HUANG JZ, XIAO N, SUN YY, WU SS, TIAN WN, LAI YJ, LI P, DU B. Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats[J]. Applied Microbiology and Biotechnology, 2021, 105(1):287-299.
    [24] 张余威,赵文俊,李伟杰. 灭活芽孢杆菌DU-106对秀丽隐杆线虫的抗衰老作用[J]. 食品科学, 2023. https://kns.cnki.net/kcms/detail//11.2206.ts.20230217.1507.026.html. ZHANG YW, ZHAO WJ, LI WJ, DU B, LI P. Effect of Inactivated Bacillus sp. DU-106 on anti-aging of C. elegans[J]. Food Science, 2023. https://kns.cnki. net/kcms/detail//11.2206.ts.20230217.1507.026.html (in Chinese).
    [25] HOU DD, DI ZH, QI RQ, WANG HX, ZHENG S, HONG YX, GUO H, CHEN HD, GAO XH. Sea buckthorn (Hippophaë rhamnoides L.) oil improves atopic dermatitis-like skin lesions via inhibition of NF-κB and STAT1 activation[J]. Skin Pharmacology and Physiology, 2017, 30(5):268-276.
    [26] KIM TH, KIM GD, AHN HJ, CHO JJ, PARK YS, PARK CS. The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice[J]. Life Sciences, 2013, 93(15):516-524.
    [27] KIM H, KIM HR, KIM NR, JEONG BJ, LEE JS, JANG S, CHUNG DK. Oral administration of Lactobacillus plantarum lysates attenuates the development of atopic dermatitis lesions in mouse models[J]. Journal of Microbiology, 2015, 53(1):47-52.
    [28] LIANG YH, LIU GR, XIE LN, SU KW, CHANG X, XU YN, CHEN JS, ZHU ZY, YANG KY, CHEN HX, DU ZY. Dendrobium candidum polysaccharide reduce atopic dermatitis symptoms and modulate gut microbiota in DNFB-induced AD-like mice[J]. Frontiers in Physiology, 2022, 13:976421.
    [29] SIDO JM, JACKSON AR, NAGARKATTI PS, NAGARKATTI M. Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation[J]. Journal of Molecular Medicine, 2016, 94(9):1039-1051.
    [30] DU HY, FU HY, LI DN, QIAO Y, WANG QW, LIU W. The expression and regulation of interleukin-33 in human epidermal keratinocytes:a new mediator of atopic dermatitis and its possible signaling pathway[J]. Journal of Interferon & Cytokine Research:the Official Journal of the International Society for Interferon and Cytokine Research, 2016, 36(9):552-562.
    [31] LEE JH, LEE YS, LEE EJ, LEE JH, KIM TY. Capsiate inhibits DNFB-induced atopic dermatitis in NC/nga mice through mast cell and CD4+ T-cell inactivation[J]. Journal of Investigative Dermatology, 2015, 135(8):1977-1985.
    [32] BALAHA MF, AHMED NJ, ALMALKI ZS, ALAHMARI AK, ALSHEHRI AM, SOLIMAN GA, HAMAD AM. Epimedin a ameliorates DNFB-induced allergic contact dermatitis in mice:role of NF-κB/NLRP3-driven pyroptosis, Nrf2/HO-1 pathway, and inflammation modulation[J]. Life Sciences, 2022, 302:120653.
    [33] KEMPURAJ D, CASTELLANI ML, PETRARCA C, FRYDAS S, CONTI P, THEOHARIDES TC, VECCHIET J. Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line[J]. Clinical and Experimental Medicine, 2006, 6(4):150-156.
    [34] HELOU DG, MARTIN SF, PALLARDY M, CHOLLET-MARTIN S, KERDINE-RÖMER S. Nrf2 involvement in chemical-induced skin innate immunity[J]. Frontiers in Immunology, 2019, 10:1004.
    [35] SCHEINMAN PL, VOCANSON M, THYSSEN JP, JOHANSEN JD, NIXON RL, DEAR K, BOTTO NC, MOROT J, GOLDMINZ AM. Contact dermatitis[J]. Nature Reviews Disease Primers, 2021, 7(1):38.
    [36] MONTELEONE M, STANLEY AC, CHEN KW, BROWN DL, BEZBRADICA JS, von PEIN JB, HOLLEY CL, BOUCHER D, SHAKESPEAR MR, KAPETANOVIC R, ROLFES V, SWEET MJ, STOW JL, SCHRODER K. Interleukin-1β maturation triggers its relocation to the plasma membrane for gasdermin-d-dependent and-independent secretion[J]. Cell Reports, 2018, 24(6):1425-1433.
    [37] de ALMADA CN, ALMADA CN, MARTINEZ R CR, SANT՚ANA AS. Paraprobiotics:evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods[J]. Trends in Food Science & Technology, 2016, 58:96-114.
    [38] NATARAJ BH, ALI SA, BEHARE PV, YADAV H. Postbiotics-parabiotics:the new horizons in microbial biotherapy and functional foods[J]. Microbial Cell Factories, 2020, 19(1):168.
    [39] LI N, RUSSELL WM, DOUGLAS-ESCOBAR M, HAUSER N, LOPEZ M, NEU J. Live and heat-killed Lactobacillus rhamnosus GG:effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats[J]. Pediatric Research, 2009, 66(2):203-207.
    [40] CRUMP GM, ZHOU JH, MASHAYEKH S, GRIMES CL. Revisiting peptidoglycan sensing:interactions with host immunity and beyond[J]. Chemical Communications (Cambridge, England), 2020, 56(87):13313-13322.
    [41] NAUCIEL C, GOGUEL AF. Inhibition of tumor growth by the peptidoglycan from Bacillus megaterium[J]. JNCI:Journal of the National Cancer Institute, 1977, 59(6):1723-1726.
    [42] JEON B, KIM HR, KIM H, CHUNG DK. In vitro and in vivo downregulation of C3 by lipoteichoic acid isolated from Lactobacillus plantarum K8 suppressed cytokine-mediated complement system activation[J]. FEMS Microbiology Letters, 2016, 363(14):fnw140.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHAO Wenjun, ZHANG Yuwei, LI Weijie, ZHAO Chaofan, LI Yanli, DU Bing, LI Pan. Therapeutic effect of Bacillus sp. DU-106 lysate on 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice[J]. Microbiology China, 2023, 50(7): 2970-2982

Copy
Share
Article Metrics
  • Abstract:212
  • PDF: 1106
  • HTML: 788
  • Cited by: 0
History
  • Received:February 20,2023
  • Adopted:March 22,2023
  • Online: July 10,2023
  • Published: July 20,2023
Article QR Code
  • WeChat ID
  • Mobile Terminal

Microbiology China ® 2025 All Rights Reserved